All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, February 1, 2023
Home » Topics » Analysis and data insight

Analysis and data insight
Analysis and data insight RSS Feed RSS

Biopharma money raised: Jan. 1-Nov. 26, 2019

Nov. 27, 2019
No Comments
Year-to-date money raised in public, private and other financings of biopharma companies.
Read More

Collaborations between biopharmaceutical companies and government/nonprofit entities: August 2019

Nov. 27, 2019
No Comments
Deals between biopharma companies and government or nonprofit entities in August 2019.
Read More

Collaborations between biopharmaceutical companies and government/nonprofit entities: September 2019

Nov. 27, 2019
No Comments
Deals between biopharma companies and government or nonprofit entities in September 2019.
Read More

Collaborations between biopharmaceutical companies and government/nonprofit entities: October 2019

Nov. 27, 2019
No Comments
Deals between biopharma companies and government or nonprofit entities in October 2019.
Read More

Collaborations between biopharmaceutical companies and government/nonprofit entities: November 2019

Nov. 27, 2019
No Comments
Deals between biopharma companies and government or nonprofit entities in November 2019.
Read More

Biggest gainers and losers for the week of Nov. 25-27, 2019

Nov. 27, 2019
No Comments
The top 10 biopharma stock gainers and losers for the week.
Read More
ESMO Asia 2019

Population-based cancer registries needed for treatment, prevention efforts

Nov. 26, 2019
By David Ho
No Comments
SINGAPORE – Population-based cancer registries were a frequent focus of discussion at the ESMO Asia Congress.
Read More
World map made of pills

Analysis by U.K. startup Medbelle highlights extent of drug pricing disparity

Nov. 26, 2019
By Nuala Moran
No Comments
LONDON – It’s no secret that American citizens pay the most for drugs, but the extent of the disparity is laid bare in a new index of the prices of 13 medicines in 50 countries worldwide.
Read More
Analysis and data insight

Gene therapy companies recover after their stock market slide

Nov. 22, 2019
By Peter Winter
No Comments
After a two-month 32% swoon in the value of the BioWorld Gene Therapy index, it has managed to recover 6% of that loss since the end of September. Contributing to the recovery was Menlo Park, Calif.-based Adverum Biotechnologies Inc., whose shares (NASDAQ:ADVM) jumped almost 80% in the period.
Read More

Money raised by biopharma: 2019 vs. 2018

Nov. 22, 2019
No Comments
Total raised in public, private and other financings of biopharma companies, comparing 2019 vs. 2018.
Read More
Previous 1 2 … 139 140 141 142 143 144 145 146 147 … 153 154 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan. 31, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 31, 2022.
  • Setpoint Medical - vagus nerve stimulation device

    Setpoint Medical lands up to $145M to advance RA implant

    BioWorld MedTech
    Bioelectronic medicine startup Setpoint Medical Corp. raised $80 million in a preferred stock financing co-led by new investors Norwest Venture Partners and...
  • Stem-cells2.png

    J.P. Morgan Healthcare Conference: ‘Bright’ year ahead for cell, gene therapies, says ARM

    BioWorld
    After long years of painstaking work, the commercialization of cell and gene therapies picked up pace in 2022, with multiple approvals. More progress is expected...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing